Trends in Medicaid Prices, Market Share, and Spending on Long-Acting Insulins, 2006-2018

This study uses Medicaid drug utilization data to describe reimbursement and market share of long-acting insulins before and after approval of new insulin products and to estimate savings associated with a “biosimilar” for insulin glargine approved in 2015.

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA
Main Authors: Hernandez, Inmaculada, Good, Chester B., Shrank, William H., Gellad, Walid F.
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2019
Assuntos:
Research Letter
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6487544/
https://ncbi.nlm.nih.gov/pubmed/30907933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2019.2990
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados